• Consensus Rating: Buy
  • Consensus Price Target: $39.33
  • Forecasted Upside: 40.53%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$27.99
▲ +0.24 (0.86%)

This chart shows the closing price for PRGO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Perrigo Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PRGO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PRGO

Analyst Price Target is $39.33
▲ +40.53% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Perrigo in the last 3 months. The average price target is $39.33, with a high forecast of $42.00 and a low forecast of $35.00. The average price target represents a 40.53% upside from the last price of $27.99.

This chart shows the closing price for PRGO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 3 contributing investment analysts is to buy stock in Perrigo. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/30/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/30/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/29/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/27/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/25/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/24/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/23/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/23/2024

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/11/2024Piper SandlerLower TargetOverweight ➝ Overweight$36.00 ➝ $35.00Low
6/13/2024Piper SandlerLower TargetOverweight ➝ Overweight$39.00 ➝ $36.00Low
4/12/2024Canaccord Genuity GroupReiterated RatingBuy ➝ Buy$42.00Low
4/8/2024Piper SandlerBoost TargetOverweight ➝ Overweight$35.00 ➝ $39.00Low
2/28/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$48.00 ➝ $41.00Low
11/17/2023Piper SandlerInitiated CoverageOverweight$37.00Low
8/9/2023JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$45.00 ➝ $48.00N/A
3/7/2023Canaccord Genuity GroupInitiated CoverageBuy$49.00Low
3/5/2023Raymond JamesBoost TargetOutperform$42.00 ➝ $43.00Low
11/9/2022Raymond JamesLower TargetOutperform$48.00 ➝ $42.00Low
9/14/2022ArgusUpgradeHold ➝ Buy$46.00Low
9/6/2022Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$48.00 ➝ $54.00Low
11/11/2021Raymond JamesLower TargetOutperform$59.00 ➝ $55.00High
10/14/2021Raymond JamesUpgradeMarket Perform ➝ Outperform$59.00Low
9/30/2021Jefferies Financial GroupUpgradeHold ➝ Buy$45.00 ➝ $63.00High
8/12/2021Royal Bank of CanadaLower TargetSector Perform$51.00 ➝ $48.00High
4/7/2021Royal Bank of CanadaInitiated CoverageSector Perform$51.00Medium
3/5/2021Morgan StanleyLower TargetEqual Weight$53.00 ➝ $45.00Low
1/6/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$59.00 ➝ $49.00N/A
10/28/2020Wells Fargo & CompanyLower TargetEqual Weight$55.00 ➝ $49.00Low
9/17/2020SVB LeerinkLower TargetOutperform$64.00 ➝ $63.00High
6/8/2020SVB LeerinkBoost TargetOutperform$55.00 ➝ $63.00High
6/7/2020Royal Bank of CanadaReiterated RatingBuyHigh
4/17/2020ArgusDowngradeBuy ➝ HoldHigh
4/2/2020Morgan StanleyLower TargetEqual Weight$54.00 ➝ $53.00High
4/1/2020Royal Bank of CanadaReiterated RatingBuy$58.00High
3/24/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$57.00Medium
3/20/2020SVB LeerinkUpgradeMarket Perform ➝ Outperform$54.00 ➝ $52.00High
3/18/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$58.00High
3/11/2020Wells Fargo & CompanyLower TargetEqual Weight$63.00 ➝ $53.00High
2/28/2020Royal Bank of CanadaLower TargetSector Perform$64.00 ➝ $58.00High
1/21/2020Cantor FitzgeraldBoost TargetOverweight$60.00 ➝ $70.00Medium
10/11/2019ArgusUpgradeHold ➝ BuyLow
9/30/2019Wells Fargo & CompanyBoost TargetMarket Perform$45.00 ➝ $52.00Medium
9/25/2019SunTrust BanksBoost TargetHold$51.00 ➝ $55.00Medium
(Data available from 7/23/2019 forward)

News Sentiment Rating

0.84 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/26/2023
  • 11 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/25/2024
  • 17 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/24/2024
  • 18 very positive mentions
  • 28 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
3/25/2024
  • 11 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/24/2024
  • 18 very positive mentions
  • 18 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
5/24/2024
  • 14 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/23/2024
  • 8 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/23/2024

Current Sentiment

  • 8 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Perrigo logo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $27.99
Low: $27.37
High: $28.16

50 Day Range

MA: $27.25
Low: $25.43
High: $30.26

52 Week Range

Now: $27.99
Low: $24.82
High: $40.28

Volume

496,583 shs

Average Volume

1,721,336 shs

Market Capitalization

$3.82 billion

P/E Ratio

N/A

Dividend Yield

3.94%

Beta

0.51

Frequently Asked Questions

What sell-side analysts currently cover shares of Perrigo?

The following Wall Street sell-side analysts have issued stock ratings on Perrigo in the last twelve months: Canaccord Genuity Group Inc., JPMorgan Chase & Co., Piper Sandler, and StockNews.com.
View the latest analyst ratings for PRGO.

What is the current price target for Perrigo?

3 Wall Street analysts have set twelve-month price targets for Perrigo in the last year. Their average twelve-month price target is $39.33, suggesting a possible upside of 41.7%. Canaccord Genuity Group Inc. has the highest price target set, predicting PRGO will reach $42.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $35.00 for Perrigo in the next year.
View the latest price targets for PRGO.

What is the current consensus analyst rating for Perrigo?

Perrigo currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PRGO will outperform the market and that investors should add to their positions of Perrigo.
View the latest ratings for PRGO.

What other companies compete with Perrigo?

How do I contact Perrigo's investor relations team?

Perrigo's physical mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company's listed phone number is (531) 709-4000 and its investor relations email address is [email protected]. The official website for Perrigo is www.perrigo.com. Learn More about contacing Perrigo investor relations.